Nature Reviews Gastroenterology & Hepatology

Nature Reviews Gastroenterology & Hepatology (commonly abbreviated as Nat. Rev. Gastroenterol. Hepatol.) is the gastroenterology and hepatology title in the Nature Reviews portfolio. The current title dates from April 2009, the journal appears monthly, and its 2025 impact factor is 57.5.Nature Reviews Gastroenterology & Hepatology（常用缩写 Nat. Rev. Gastroenterol. Hepatol.）是 Nature Reviews 系列的胃肠病学与肝病学综述期刊，现刊名始于 2009 年 4 月，为月刊，2025 年影响因子为 57.5。^[1]

Scope

• Scope: basic, translational and clinical content is written by internationally renowned basic and clinical academics and researchers and targeted at readers in the biological and medical sciences from postgraduate level upwards, while aiming to make all articles accessible to readers working in any biological or medical discipline.学科定位： 基础、转化与临床内容由国际知名的基础与临床学者撰写，面向研究生及以上层次的生物医学读者，并力求使任何生物医学学科的读者都能读懂。
• Topics: gastrointestinal cancers, endoscopy and imaging, epidemiology, the gut microbiota, viral hepatitis, inflammatory bowel disease, cirrhosis and fibrosis, motility disorders, nutrition, pancreatic disease, paediatrics, gastrointestinal surgery and pharmacotherapy.收录主题： 胃肠道肿瘤、内镜与影像、流行病学、肠道微生物群、病毒性肝炎、炎症性肠病、肝硬化与肝纤维化、动力障碍、营养、胰腺疾病、儿科、胃肠外科与药物治疗等。
• Article types: commissioned content only, comprising in-depth reviews, consensus statements, perspectives, comments, news and views, and research highlights.文章体裁： 仅发表约稿内容，包括深度综述、共识声明、观点、评论、新闻与观点及研究亮点。^[2]
• Publishing model: subscription only, with no immediate gold OA option and no publication fee, while authors may self-archive the accepted manuscript six months after online publication.出版模式： 纯订阅路线，不提供立即 Gold OA 选项，不收取发表费，在线发表 6 个月后作者可自存录用稿。^[3]
• Indexing and metrics: indexed for MEDLINE, the journal reports a 2025 impact factor of 57.5 and a five-year impact factor of 73.1.收录与指标： 为 MEDLINE 收录，2025 年影响因子 57.5，五年影响因子 73.1。^[4]

History

• Predecessor: the journal descends from Nature Clinical Practice Gastroenterology & Hepatology, founded in 2004.前身创刊： 前身 Nature Clinical Practice Gastroenterology & Hepatology 创于 2004 年。
• Renaming: the current title was adopted in April 2009, with volume numbering continuing from the predecessor's volume 6 and the ISSNs changing to 1759-5045 and 1759-5053.更名： 2009 年 4 月起改用现名，卷期自前身第 6 卷接续，ISSN 同时变更为 1759-5045 与 1759-5053。^[5]
• Publisher: published by Nature Portfolio within Springer Nature as part of the Nature Reviews family.出版方： 现由 Springer Nature 旗下的 Nature Portfolio 出版，隶属 Nature Reviews 系列。
• Editorial transition: Katrina Ray has been chief editor since August 2014, having joined the title as associate editor in 2011 and become senior editor in 2012.主编更替： Katrina Ray 于 2014 年 8 月起任主编，此前自 2011 年起历任本刊副编辑与高级编辑。^[6]

Editors

• Editor-in-chief: Katrina Ray, a microbiologist by training whose doctoral work concerned Shigella, covering gastroenterology, the microbiota, infection and viral hepatitis.现任主编： Katrina Ray，微生物学出身，博士课题研究志贺菌，研究方向覆盖胃肠病学、微生物群、感染与病毒性肝炎。
• Other editors: senior editors Jordan Hindson for liver disease and translational medicine and Eleni Kotsiliti for liver disease, immunology and the gut-liver axis.其他编辑： 高级编辑 Jordan Hindson 负责肝病与转化医学，Eleni Kotsiliti 负责肝病、免疫学与肠肝轴。
• Editorial board: edited by a full-time in-house team, advised by an external advisory board of internationally renowned scientists and clinicians.编委构成： 由全职内部编辑团队主编，并设国际知名学者与临床医生组成的外部顾问委员会提供咨询。
• Submission and review: manuscripts are submitted through Nature's own tracking system.投稿与评审： 稿件经 Nature 自建投稿系统递交。